JP2023516713A5 - - Google Patents
Info
- Publication number
- JP2023516713A5 JP2023516713A5 JP2022552880A JP2022552880A JP2023516713A5 JP 2023516713 A5 JP2023516713 A5 JP 2023516713A5 JP 2022552880 A JP2022552880 A JP 2022552880A JP 2022552880 A JP2022552880 A JP 2022552880A JP 2023516713 A5 JP2023516713 A5 JP 2023516713A5
- Authority
- JP
- Japan
- Prior art keywords
- ep402r
- gene
- asf virus
- attenuated
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2003292.6 | 2020-03-06 | ||
| GBGB2003292.6A GB202003292D0 (en) | 2020-03-06 | 2020-03-06 | Vaccine |
| GBGB2003289.2A GB202003289D0 (en) | 2020-03-06 | 2020-03-06 | Vaccine |
| GB2003289.2 | 2020-03-06 | ||
| GB2005880.6 | 2020-04-22 | ||
| GB2005878.0 | 2020-04-22 | ||
| GBGB2005880.6A GB202005880D0 (en) | 2020-04-22 | 2020-04-22 | Vaccine |
| GBGB2005878.0A GB202005878D0 (en) | 2020-04-22 | 2020-04-22 | Vaccine |
| GB2013541.4 | 2020-08-28 | ||
| GBGB2013541.4A GB202013541D0 (en) | 2020-08-28 | 2020-08-28 | Vaccine |
| PCT/GB2021/050562 WO2021176236A1 (en) | 2020-03-06 | 2021-03-05 | Vaccine against african swine fever virus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516713A JP2023516713A (ja) | 2023-04-20 |
| JP2023516713A5 true JP2023516713A5 (https=) | 2024-03-11 |
Family
ID=74870840
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552880A Pending JP2023516713A (ja) | 2020-03-06 | 2021-03-05 | アフリカ豚熱ウイルス感染に対するワクチン |
| JP2022552870A Pending JP2023516709A (ja) | 2020-03-06 | 2021-03-05 | アフリカ豚熱ウイルス感染に対するワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552870A Pending JP2023516709A (ja) | 2020-03-06 | 2021-03-05 | アフリカ豚熱ウイルス感染に対するワクチン |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20240293525A1 (https=) |
| EP (3) | EP4114454A1 (https=) |
| JP (2) | JP2023516713A (https=) |
| KR (2) | KR20230013016A (https=) |
| CN (3) | CN115397463A (https=) |
| AU (2) | AU2021229654A1 (https=) |
| BR (2) | BR112022016893A8 (https=) |
| CA (2) | CA3170043A1 (https=) |
| CL (2) | CL2022002412A1 (https=) |
| CO (2) | CO2022014152A2 (https=) |
| MX (2) | MX2022010373A (https=) |
| PH (2) | PH12022552084A1 (https=) |
| WO (3) | WO2021176235A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201910794D0 (en) * | 2019-07-29 | 2019-09-11 | Pirbright Inst | Vaccine |
| CN120282794A (zh) * | 2022-08-04 | 2025-07-08 | T·马尔科姆 | 针对非洲猪瘟病毒的猪的预防和感染后治疗的显性负性抗原方法 |
| WO2024057048A1 (en) * | 2022-09-12 | 2024-03-21 | Consejo Superior De Investigaciones Científicas | Attenuated african swine fever virus and use thereof in vaccine compositions |
| WO2024110451A1 (en) * | 2022-11-22 | 2024-05-30 | Intervet International B.V. | Attenuated african swine fever virus and use thereof in vaccine compositions |
| WO2024110453A1 (en) * | 2022-11-22 | 2024-05-30 | Gold Standard Diagnostics Madrid, S.A. | Method for differentiating asfv infected from asfv vaccinated animals |
| CN117224669B (zh) * | 2023-07-31 | 2024-07-30 | 中国农业科学院兰州兽医研究所 | 非洲猪瘟病毒mgf360-21r蛋白作为免疫诱导剂或者佐剂的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015091322A1 (en) * | 2013-12-18 | 2015-06-25 | Boehringer Ingelheim Vetmedica Gmbh | Cd2 deficient african swine fever virus as live attenuated or subsequently inactivated vaccine against african swine fever in mammals |
| GB201410971D0 (en) * | 2014-06-19 | 2014-08-06 | Pirbright Inst The | Vaccine |
| US9528094B2 (en) * | 2014-11-10 | 2016-12-27 | The United States Of America, As Represented By The Secretary Of Agriculture | Attenuated African swine fever virus vaccine based in the deletion of MGF genes |
| CN110551695A (zh) * | 2019-08-14 | 2019-12-10 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 非洲猪瘟病毒四基因缺失弱毒株及其应用 |
-
2021
- 2021-03-05 WO PCT/GB2021/050561 patent/WO2021176235A1/en not_active Ceased
- 2021-03-05 CN CN202180019234.9A patent/CN115397463A/zh active Pending
- 2021-03-05 BR BR112022016893A patent/BR112022016893A8/pt unknown
- 2021-03-05 JP JP2022552880A patent/JP2023516713A/ja active Pending
- 2021-03-05 KR KR1020227034852A patent/KR20230013016A/ko active Pending
- 2021-03-05 CN CN202180019437.8A patent/CN115605223A/zh active Pending
- 2021-03-05 WO PCT/GB2021/050562 patent/WO2021176236A1/en not_active Ceased
- 2021-03-05 MX MX2022010373A patent/MX2022010373A/es unknown
- 2021-03-05 US US17/905,490 patent/US20240293525A1/en active Pending
- 2021-03-05 MX MX2022010372A patent/MX2022010372A/es unknown
- 2021-03-05 CA CA3170043A patent/CA3170043A1/en active Pending
- 2021-03-05 PH PH1/2022/552084A patent/PH12022552084A1/en unknown
- 2021-03-05 JP JP2022552870A patent/JP2023516709A/ja active Pending
- 2021-03-05 US US17/905,488 patent/US20230117978A1/en active Pending
- 2021-03-05 AU AU2021229654A patent/AU2021229654A1/en active Pending
- 2021-03-05 PH PH1/2022/552086A patent/PH12022552086A1/en unknown
- 2021-03-05 EP EP21711339.8A patent/EP4114454A1/en active Pending
- 2021-03-05 WO PCT/GB2021/050560 patent/WO2021176234A1/en not_active Ceased
- 2021-03-05 EP EP21711340.6A patent/EP4114455A1/en active Pending
- 2021-03-05 CN CN202180019982.7A patent/CN116133680A/zh active Pending
- 2021-03-05 AU AU2021231402A patent/AU2021231402A1/en active Pending
- 2021-03-05 US US17/905,492 patent/US20230124042A1/en active Pending
- 2021-03-05 EP EP21711338.0A patent/EP4114453A1/en active Pending
- 2021-03-05 KR KR1020227034853A patent/KR20230013017A/ko active Pending
- 2021-03-05 CA CA3170058A patent/CA3170058A1/en active Pending
- 2021-03-05 BR BR112022016891A patent/BR112022016891A2/pt unknown
-
2022
- 2022-09-05 CL CL2022002412A patent/CL2022002412A1/es unknown
- 2022-09-05 CL CL2022002416A patent/CL2022002416A1/es unknown
- 2022-10-03 CO CONC2022/0014152A patent/CO2022014152A2/es unknown
- 2022-10-05 CO CONC2022/0014256A patent/CO2022014256A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023516713A5 (https=) | ||
| JP2023516709A5 (https=) | ||
| Gane et al. | Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: results from randomized clinical trials | |
| Streicher | Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics | |
| Lazear et al. | Shared and distinct functions of type I and type III interferons | |
| JP2018523668A5 (https=) | ||
| Cantin et al. | Gamma interferon (IFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ ligand null-mutant mice | |
| JP2022051775A5 (https=) | ||
| JP2019508045A5 (https=) | ||
| JP2016538885A5 (https=) | ||
| JP2006518372A5 (https=) | ||
| KR20180081616A (ko) | 항-vegf로 치료된 연령-관련 황반 변성을 앓고 있는 환자에서의 임상 결과와 유전적 변이체를 연관시키는 방법 | |
| JP2023504773A5 (https=) | ||
| Xu et al. | Differential modulation of avian β-defensin and Toll-like receptor expression in chickens infected with infectious bronchitis virus | |
| JP2021500016A5 (https=) | ||
| JP2019515663A5 (https=) | ||
| MX2023006694A (es) | Tratamiento de la enfermedad de danon. | |
| US20230124042A1 (en) | Vaccine against african swine fever virus infection | |
| Park et al. | Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-γ | |
| JP2023522154A5 (https=) | ||
| CA3242351A1 (en) | Methods and compositions for treating bag-3 related cardiomyopathy with a viral vector | |
| CN1455674B (zh) | 绵羊副痘病毒菌株用于制备抗病毒药物和抗癌药物的用途 | |
| JP2022536945A5 (https=) | ||
| RU2018142174A (ru) | Контролируемая пищевым рационом экспрессия нуклеиновой кислоты, кодирующей нуклеазу cas9, и ее применения | |
| CA3242262A1 (en) | Methods and compositions for treating mybpc3 related hypertrophic cardiomyopathy with a viral vector |